Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49.

Article  Google Scholar 

Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380:1450–62.

Article  CAS  PubMed  Google Scholar 

Galle PR, Tovoli F, Foerster F, Worns MA, Cucchetti A, Bolondi L. The treatment of intermediate stage tumours beyond TACE: from surgery to systemic therapy. J Hepatol. 2017;67:173–83.

Article  PubMed  Google Scholar 

Sangro B, Sarobe P, Hervas-Stubbs S, Melero I. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:525–43.

Article  PubMed  PubMed Central  Google Scholar 

Zheng C, Zheng L, Yoo JK, Guo H, Zhang Y, Guo X, Kang B, et al. Landscape of infiltrating T cells in Liver Cancer revealed by single-cell sequencing. Cell. 2017;169:1342–56. e16.

Article  CAS  PubMed  Google Scholar 

Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, Modak M et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829 – 45.e20.

Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, Pikarsky E, et al. Immunotherapies for hepatocellular carcinoma. Nat Reviews Clin Oncol. 2021;19:151–72.

Article  Google Scholar 

Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W. Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Commun (Lond). 2022;42:1112–40.

Article  PubMed  Google Scholar 

Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, Rizvi SM, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021;27:152–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho DW, Tsui YM, Chan LK, Sze KM, Zhang X, Cheu JW, Chiu YT, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, Rao L, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Therapy. 2023;8:207.

Article  Google Scholar 

Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799–820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, et al. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. 2017;66:157–67.

Article  CAS  PubMed  Google Scholar 

Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, Gupta R, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu LG, Zhou ZL, Wang XY, Liu BY, Lu JY, Liu S, Zhang GB et al. PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma. Gut. 2022.

Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, Krishnan V, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572:392–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei R, Zhu W-W, Yu G-Y, Wang X, Gao C, Zhou X, Lin Z-F, et al. S100 calcium-binding protein A9 from tumor-associated macrophage enhances cancer stem cell-like properties of hepatocellular carcinoma. Int J Cancer. 2021;148:1233–44.

Article  PubMed  Google Scholar 

Sprinzl MF, Puschnik A, Schlitter AM, Schad A, Ackermann K, Esposito I, Lang H, et al. Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. J Hepatol. 2015;62:863–70.

Article  CAS  PubMed  Google Scholar 

Chen J, Lin Z, Liu L, Zhang R, Geng Y, Fan M, Zhu W, et al. GOLM1 exacerbates CD8 + T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages. Signal Transduct Target Therapy. 2021;6:397.

Article  CAS  Google Scholar 

Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, Li CW, et al. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 2019;68:1653–66.

Article  CAS  PubMed  Google Scholar 

Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, Rong D, et al. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou S-L, Yin D, Hu Z-Q, Luo C-B, Zhou Z-J, Xin H-Y, Yang X-R et al. A positive Feedback Loop between Cancer Stem-Like cells and Tumor-Associated neutrophils Controls Hepatocellular Carcinoma Progression. Hepatology (Baltimore, Md.). 2019;70:1214–30.

Yu SJ, Ma C, Heinrich B, Brown ZJ, Sandhu M, Zhang Q, Fu Q, et al. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. J Hepatol. 2019;70:449–57.

Article  CAS  PubMed  Google Scholar 

Geh D, Leslie J, Rumney R, Reeves HL, Bird TG, Mann DA. Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:257–73.

Article  CAS  PubMed  Google Scholar 

Wong L, Bozhilov K, Hernandez B, Kwee S, Chan O, Ellis L, LeMarchand L. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio. Clin Mol Hepatol. 2019;25:305–16.

Article  PubMed  PubMed Central  Google Scholar 

Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, Schneider AH et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217.

Kaplan MJ, Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol. 2012;189:2689–95.

Article  CAS  PubMed  Google Scholar 

Yang L, Liu Q, Zhang X, Liu X, Zhou B, Chen J, Huang D, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 2020;583:133–8.

Article  CAS  PubMed  Google Scholar 

Xiao Y, Cong M, Li J, He D, Wu Q, Tian P, Wang Y et al. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell. 2021;39.

van der Windt DJ, Sud V, Zhang H, Varley PR, Goswami J, Yazdani HO, Tohme S, et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology (Baltimore MD). 2018;68:1347–60.

Article  CAS  PubMed  Google Scholar 

Yang L-Y, Luo Q, Lu L, Zhu W-W, Sun H-T, Wei R, Lin Z-F, et al. Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J Hematol Oncol. 2020;13:3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, Feng M, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612:141–7.

Article  CAS  PubMed  Google Scholar 

Wang L, Liu Y, Dai Y, Tang X, Yin T, Wang C, Wang T, et al. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment. Gut. 2023;72:958–71.

Article  CAS  PubMed  Google Scholar 

Meng Y, Ye F, Nie P, Zhao Q, An L, Wang W, Qu S et al. Immunosuppressive CD10 + ALPL + neutrophils promote resistance to anti-PD-1 therapy in HCC ​by mediating irreversible exhaustion of T cells. J Hepatol. 2023.

Gungabeesoon J, Gort-Freitas NA, Kiss M, Bolli E, Messemaker M, Siwicki M, Hicham M et al. A neutrophil response linked to tumor control in immunotherapy. Cell. 2023;186.

Hirschhorn D, Budhu S, Kraehenbuehl L, Gigoux M, Schröder D, Chow A, Ricca JM et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell. 2023;186.

Del Prete A, Salvi V, Soriani A, Laffranchi M, Sozio F, Bosisio D, Sozzani S. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell Mol Immunol. 2023;20:432–47.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Z-J, Xin H-Y, Li J, Hu Z-Q, Luo C-B, Zhou S-L. Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection. Cancer Immunol Immunotherapy: CII. 2019;68:1223–33.

Article  PubMed Central  Google Scholar 

Pang L, Ng KT-P, Liu J, Yeung W-HO, Zhu J, Chiu T-LS, Liu H, et al. Plasmacytoid dendritic cells recruited by HIF-1α/eADO/ADORA1 signaling induce immunosuppression in hepatocellular carcinoma. Cancer Lett. 2021;522:80–92.

Article  CAS  PubMed  Google Scholar 

Pedroza-Gonzalez A, Zhou G, Vargas-Mendez E, Boor PP, Mancham S, Verhoef C, Polak WG, et al. Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors. Oncoimmunology. 2015;4:e1008355.

Article  PubMed  PubMed Central  Google Scholar 

Suthen S, Lim CJ, Nguyen PHD, Dutertre CA, Lai HLH, Wasser M, Chua C, et al. Hypoxia-driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC. Hepatology. 2022;76:1329–44.

Article  CAS  PubMed  Google Scholar 

Akkaya B, Oya Y, Akkaya M, Al Souz J, Holstein AH, Kamenyeva O, Kabat J, et al. Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells. Nat Immunol. 2019;20:218–31.

Article  CAS  PubMed  PubMed Central